Get started
Author

Takahiro Hasegawa

Observed names: Hasegawa, Takahiro, Takahiro HASEGAWA
Institution: Shionogi (Japan)
ORCID: 0000-0003-2014-5621
Observed ORCID: 0000-0003-2014-5621
OpenAlex ID: A5090014567
Restricted mean survival time as a summary measure of time‐to‐event outcome
2020 · Takahiro Hasegawa, Saori Misawa, et al. · Pharmaceutical Statistics · 54
Sample size determination for the weighted log‐rank test with the Fleming–Harrington class of weights in cancer vaccine studies
2014 · Takahiro Hasegawa · Pharmaceutical Statistics · 46
Robust Alternatives to ANCOVA for Estimating the Treatment Effect via a Randomized Comparative Study
2018 · Fei Jiang, Lu Tian, et al. · Journal of the American Statistical Association · 29
PDF
Pharmacokinetic and pharmacodynamic analysis of baloxavir marboxil, a novel cap-dependent endonuclease inhibitor, in a murine model of influenza virus infection
2020 · Yoshinori Ando, Takeshi Noshi, et al. · Journal of Antimicrobial Chemotherapy · 28
PDF
Group sequential monitoring based on the weighted log‐rank test statistic with the Fleming–Harrington class of weights in cancer vaccine studies
2016 · Takahiro Hasegawa · Pharmaceutical Statistics · 28
Clinical and virologic effects of four neuraminidase inhibitors in influenza A virus-infected children (aged 4–12 years): an open-label, randomized study in Japan
2017 · Nobuo Hirotsu, Yutaka Saisho, et al. · Expert Review of Anti-infective Therapy · 20
PDF
Beneficial effect of body weight control on left ventricular diastolic function in the general population: an analysis of longitudinal data from a health check-up clinic
2017 · Seitetz C Lee, Masao Daimon, et al. · European Heart Journal - Cardiovascular Imaging · 19
Permutation Test Following Covariate-Adaptive Randomization in Randomized Controlled Trials
2009 · Takahiro Hasegawa, Toshiro Tango · Journal of Biopharmaceutical Statistics · 18
The effect of neuraminidase inhibitors on household transmission in Japanese patients with influenza A and B infection: A prospective, observational study
2018 · Nobuo Hirotsu, Yutaka Saisho, et al. · Influenza and Other Respiratory Viruses · 14
A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma
2024 · Tomoki Makino, Hiroshi Miyata, et al. · Esophagus · 13
PDF
A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults
2024 · Satoshi Iwata, Andrew J. Pollard, et al. · Scientific Reports · 9
The Myth of Making Inferences for an Overall Treatment Efficacy with Data from Multiple Comparative Studies Via Meta-Analysis
2016 · Takahiro Hasegawa, Brian Claggett, et al. · Statistics in Biosciences · 8
The relationship between in vivo antiviral activity and pharmacokinetic parameters of peramivir in influenza virus infection model in mice
2014 · Makoto Kodama, Ryu Yoshida, et al. · Antiviral Research · 7
Reconstructing the household transmission of influenza in the suburbs of Tokyo based on clinical cases
2021 · Masaya M. Saito, Nobuo Hirotsu, et al. · Theoretical Biology and Medical Modelling · 6
PDF
Neratinib after trastuzumab in patients with HER2-positive breast cancer
2016 · Takahiro Hasegawa, Hajime Uno, et al. · The Lancet Oncology · 5
Antibody dynamics in Japanese paediatric patients with influenza A infection treated with neuraminidase inhibitors in a randomised trial
2019 · Nobuo Hirotsu, Yutaka Saisho, et al. · Scientific Reports · 4
PDF
How to Summarize the Safety Profile of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy?
2016 · Takahiro Hasegawa, Hajime Uno, et al. · Journal of Clinical Oncology · 4
A Phase 2 Study of S-588410 Maintenance Monotherapy for Platinum-Treated Advanced or Metastatic Urothelial Carcinoma
2022 · Nobuaki Shimizu, Syed A. Hussain, et al. · Bladder Cancer · 3
PDF
Phase II open-label study of S-588410 as maintenance monotherapy after first-line platinum-containing chemotherapy in patients with advanced or metastatic urothelial carcinoma.
2021 · Syed A. Hussain, Nobuaki Shimizu, et al. · Journal of Clinical Oncology · 2
Zoledronic Acid Dosing in Patients With Metastatic Breast Cancer
2017 · Takahiro Hasegawa, Hajime Uno, et al. · JAMA Oncology · 1
Comparison of the Kinetics of Granulocytes and Lymphocytes between Influenza A/H1N1/pdm 09 and Seasonal Influenza A
2014 · Nobuo HIROTSU, Takahiro HASEGAWA, et al. · Kansenshogaku zasshi · 1
PDF
Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study
2026 · Kimura, Ryusei, Nomura, Shogo, et al. · Figshare
Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study
2026 · Ryusei Kimura, Shogo Nomura, et al. · Journal of Biopharmaceutical Statistics
P-1606. Clearance of Infectious Virus in COVID-19 Patients Treated with Ensitrelvir Across Vaccination Status, Age, and Risk Subgroups: Exploratory Analyses from the SCORPIO-HR Study
2026 · Florin Draica, Annie Luetkemeyer, et al. · Open Forum Infectious Diseases
Sample Size Determination and Information Fraction Based on the Weighted log-rank Test with the Fleming—Harrington Class of Weights and a Test of the Difference in Restricted Mean Survival Time
2024 · Takahiro Hasegawa · Japanese Journal of Biometrics
PDF
Works count: 27
Citation count: 319
H-index: 10
I10-index: 10
Year
Topic
Type